Table 1 Patient characteristics (n = 45)
From: Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy
| Parameter | Gal-1 expression (weak) | Gal-1 expression (strong) | p value |
|---|---|---|---|
| Age (years) | 0.464 | ||
| < 50 | 5 (45.5%) | 10 (29.4%) | |
| ≥ 50 | 6 (54.5%) | 24 (70.6%) | |
| Gender | 0.732 | ||
| Female | 5 (45.5%) | 13 (38.2%) | |
| Male | 6 (54.5%) | 21 (61.8%) | |
| ECOG | 1.000 | ||
| 0–2 | 8 (72.7%) | 26 (76.5%) | |
| 3–4 | 3 (27.3%) | 8 (23.5%) | |
| Tumor size | 0.897 | ||
| < 5 cm | 3 (27.3%) | 7 (20.6%) | |
| ≥ 5 cm | 2 (18.2%) | 7 (20.6%) | |
| Unknown | 6 (54.5%) | 20 (58.8%) | |
| OP method | 0.525 | ||
| gross total removal | 8 (72.7%) | 17 (50.0%) | |
| subtotal removal + biopsy | 3 (27.3%) | 14 (41.2%) | |
| unknown | 0 (0%) | 3 (8.8%) | |
| RT field | 0.736 | ||
| Small | 7 (63.6%) | 19 (55.9%) | |
| Whole brain | 4 (36.4%) | 15 (44.1%) | |
| EQD2 (Gy) | 0.987 | ||
| Mean | 66.36 | 66.38 | |
| SEM | 0.67 | 0.46 |
